MIKHAIL VASSILENKO: Open Payments
NPI 1053380584 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 25 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $169 |
| Janssen Pharmaceuticals, Inc | 3 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Alkermes, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Tris Pharma Inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
Products named: VRAYLAR, SPRAVATO, TRINTELLIX, LYBALVI, CAPLYTA, INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across FL — which companies pay providers there.
